MESSAGE FROM THE PRESIDENT
Dear Colleagues
M
y name is Marc Gabel
and I am most honoured
to be the President of
this College for the coming year.
My focus during this time will be
on the twin issues of professionalism and transparency. Both of these
elements are key to building the
public’s trust and confidence in us
– the former as part of the mission
to enhance patient care and reduce
patient complaints, the latter as
evidence that we are worthy of
regulating ourselves in the public
interest.
Our relationships with the pharmaceutical industry, as well as other
health-related commercial enterprises, are inextricably linked with
transparency, trust and professionalism. Interactions with industry have long been a part of our
professional lives, and while they
have value and benefit, they are not
without risk.
Marc Gabel, MD
College President
First and foremost, we need to
understand that the relationship we
have with industry is, at its core, a
business relationship. Granted, it is
a relationship that may contribute
to the provision of the best possible
care for our patients, but we can’t
lose sight of the fact that we may
not al ݅